Thornhill Research has been awarded an $8,049,024 USD five-year, firm-fixed-priced, indefinite-quantity/indefinite-delivery contract by the U.S. Department of Defense (DoD) through the Canadian Commercial Corporation (CCC) (Ottawa, Ontario, Canada) to provide Field Anesthesia Systems to administer general anesthesia to patients requiring emergency medical procedures in a field environment.
MADM (Mobile Anesthesia Delivery Module) is the world’s first inline direct injection anesthetic vaporiser.
Connect it to any ventilator and instantly you can deliver gas anesthesia, safely and accurately, anywhere your mission takes you.
MADM works by measuring anesthetic in the inspiratory limb of the breathing circuit, calculating how much liquid anesthetic to inject and vaporise, and delivering that into the circuit to produce the concentration set for the patient.
MADM works with transport ventilators and resuscitation bags in austere environments.
It can also be placed into a circle system ventilator circuit safely, automatically reducing the anesthetic injected to compensate for vapor returning from the ventilator.
MADM is the first digital in-circuit anesthesia delivery device. It can be added to any ventilator to effectively turn it into an anesthesia machine.
With the anesthesia in-circuit, it’s much simpler to monitor and control the amount delivered to the patient.
This has many benefits:
- More compact and economical equipment
- Faster (inspired concentrations achieve target within a few breaths)
- Faster operator training
- Potentially safer for patients (no need to overpressure circuit to achieve rapid induction)
The MADM device is also a comprehensive Anesthetic monitoring device.
MADM Monitors:
- Agent Selection
- Anesthetic Concentration Delivered
- End Tidal Anesthetic Concentration
- Respiration Rate
- PICO2
- PETCO2
- VE
The MADM’s many advantages make it the practical solution for a wide variety of anesthesia applications. MADM’s mobility and ease-of-use make it ideal for remote community hospitals and field use.
“The US Marine Corps have been a longtime partner with Thornhill Research Inc.,”,” stated Kipton Lade, President and CEO of Thornhill Research Inc.
“We are honored to continue providing lifesaving technologies to this very important client.”
Work will be performed at Thornhill Research’s facility in Toronto, Ontario, Canada, and is expected to be complete by April 23, 2018.
If all options are exercised, work will continue through April 23, 2022. This contract includes a base period of performance with four, one-year option periods, which if exercised, would bring the total contract value to $14,200,328 USD.
Fiscal 2017 operations and maintenance (Marine Corps) funds in the amount of $313,483 USD will be obligated on the first delivery order issued concurrent at time of award.
This contract was competitively procured via the Federal Business Opportunities website, with one offer received. The Marine Corps Systems Command, Quantico, Virginia, is the contracting activity (M67854-17-D-5006).
Thornhill Research makes innovative healthcare devices.
Our founder, Dr. Joseph Fisher, is a world-renowned research scientist in the field of anesthesiology and cardiovascular intensive care.
Since spinning off from the University Health Network in 2003, Thornhill Research has built upon his expertise to develop and manufacture compact mobile emergency respiration and anesthesia devices.
